Detalhe da pesquisa
1.
Linkage of resistance-associated substitutions in GT1 sofosbuvir + NS5A inhibitor failures treated with glecaprevir/pibrentasvir.
J Hepatol
; 75(4): 820-828, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023351
2.
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: A meta-analysis.
J Hepatol
; 72(6): 1112-1121, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32061651
3.
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy.
Gastroenterology
; 157(6): 1506-1517.e1, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31401140
4.
Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials.
Antimicrob Agents Chemother
; 62(10)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061289
5.
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin.
Liver Int
; 38(9): 1571-1575, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29377566
6.
Safety of the 2D/3D direct-acting antiviral regimen in HCV-induced Child-Pugh A cirrhosis - A pooled analysis.
J Hepatol
; 67(4): 700-707, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28645740
7.
Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
N Engl J Med
; 370(17): 1594-603, 2014 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24720703
8.
Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.
N Engl J Med
; 370(3): 222-32, 2014 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24428468
9.
Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.
N Engl J Med
; 370(17): 1604-14, 2014 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24720679
10.
Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks.
J Hepatol
; 64(2): 301-307, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26476290
11.
Exploratory study of oral combination antiviral therapy for hepatitis C.
N Engl J Med
; 368(1): 45-53, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23281975
12.
Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvir.
Antimicrob Agents Chemother
; 59(9): 5445-54, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26100711
13.
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1.
J Hepatol
; 59(1): 18-23, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23439262
14.
Validation of the PAGI-SYM and PAGI-QOL among healing and maintenance of erosive esophagitis clinical trial participants.
Qual Life Res
; 19(4): 551-64, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20195905
15.
Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection.
J Gastroenterol
; 54(8): 752-761, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30868245
16.
Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4.
Hepatol Commun
; 2(11): 1311-1319, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411078
17.
Overview of multiple testing methodology and recent development in clinical trials.
Contemp Clin Trials
; 45(Pt A): 13-20, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26210511
18.
Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata.
Semin Reprod Med
; 22(2): 113-9, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15164306
19.
Evaluation of the pharmacokinetics and pharmacodynamics of two leuprolide acetate 45 mg 6-month depot formulations in patients with prostate cancer.
Clin Pharmacol Drug Dev
; 3(4): 270-5, 2014 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27128832
20.
Pharmacokinetic and exposure-response analyses of leuprolide following administration of leuprolide acetate 3-month depot formulations to children with central precocious puberty.
Clin Drug Investig
; 34(7): 441-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24756362